Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, and Eli Lilly (LLY), which produces Zepbound.
Read more...
Hence then, the article about amgen just got one step closer to bringing its monthly weight loss drug to market was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen just got one step closer to bringing its monthly weight loss drug to market )
Also on site :
- Six AI Code Generation Solutions Named Champions in Info-Tech Research Group's 2026 Emotional Footprint Report
- PNC Bank, N.A. Changes Prime Rate
- First Horizon Bank's Jimmy Dunn and Mary Lakey Receive 2026 New Orleans CityBusiness Leadership Awards